Merck Says Cyberattack Hit Production, Will Hurt Profit

Merck said its second-quarter earnings rose as the drugmaker recorded blockbuster growth for its cancer drug Keytruda.

from WSJ.com: US Business http://ift.tt/2v7Qnq4
via IFTTT